Literature DB >> 2059153

Bis(tri-n-butyltin)oxide induces programmed cell death (apoptosis) in immature rat thymocytes.

M Raffray1, G M Cohen.   

Abstract

In order to characterise the mechanism of cytotoxicity of the immunotoxic organotin compound bis(tri-n-butyltin)oxide (TBTO) to lymphoid cells, isolated thymocytes from immature rats were exposed to TBTO (0.1-5 microM) for up to 6 h. At lower TBTO concentrations (0.1 and 1 microM) vital staining showed that only marginal loss of viability occurred, although morphological studies demonstrated increased numbers of cells with abnormal features indicative of programmed cell death (apoptosis). These changes included nuclear chromatin condensation (which was associated with increased DNA fragmentation), cytoplasmic contraction and formation of membrane bound apoptotic bodies. When visualised by agarose gel electrophoresis, genomic DNA appeared as a series of fragments with a repeat multiple of 180-200 base pairs. Comparable morphological changes and cleavage of DNA into oligonucleosomal fragments were evident in thymocytes incubated with 10 microM methyl prednisolone hemisuccinate (MPS); a glucocorticoid hormone known to induce programmed cell death in thymocytes. Marked cytotoxicity associated with degenerative changes indicative of necrosis was observed in thymocytes incubated with 5 microM TBTO. These findings indicate that, at levels which are not overtly cytotoxic, TBTO is capable of inducing programmed cell death in rat thymocytes. This suggests a possible mechanism for the T-cell immunodeficiency previously reported for TBTO in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059153     DOI: 10.1007/bf02034940

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  23 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures.

Authors:  C A Smith; G T Williams; R Kingston; E J Jenkinson; J J Owen
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

3.  Immune suppression as a consequence of a selective cytotoxic activity of certain organometallic compounds on thymus and thymus-dependent lymphocytes.

Authors:  W Seinen; A Penninks
Journal:  Ann N Y Acad Sci       Date:  1979-05-31       Impact factor: 5.691

4.  What is apoptosis?

Authors:  A H Wyllie
Journal:  Histopathology       Date:  1986-09       Impact factor: 5.087

5.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.

Authors:  J J Cohen; R C Duke
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  Studies of the mechanism of glucocorticoid-induced pyknosis in isolated rat thymocytes.

Authors:  N Thomas; J L Edwards; P A Bell
Journal:  J Steroid Biochem       Date:  1983-05       Impact factor: 4.292

7.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

Review 8.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

9.  Evidence for the internucleosomal breakage of chromatin in rat thymocytes irradiated in vitro.

Authors:  T Yamada; H Ohyama; Y Kinjo; M Watanabe
Journal:  Radiat Res       Date:  1981-03       Impact factor: 2.841

10.  Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance.

Authors:  J Searle; J F Kerr; C J Bishop
Journal:  Pathol Annu       Date:  1982
View more
  9 in total

1.  Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation.

Authors:  G M Cohen; X M Sun; R T Snowden; D Dinsdale; D N Skilleter
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

2.  Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition.

Authors:  C Kayalar; T Ord; M P Testa; L T Zhong; D E Bredesen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes.

Authors:  J Beyette; G G Mason; R Z Murray; G M Cohen; A J Rivett
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

4.  The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells.

Authors:  G Tezel; M B Wax
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

5.  Thymocyte apoptosis as a mechanism for tributyltin-induced thymic atrophy in vivo.

Authors:  M Raffray; G M Cohen
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

6.  The cortical epithelium of the rat thymus after in vivo exposure to bis(tri-n-butyltin)oxide (TBTO). An (immuno)histological and ultrastructural study.

Authors:  E J De Waal; H J Schuurman; L H Rademakers; H Van Loveren; J G Vos
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis.

Authors:  P X Petit; H Lecoeur; E Zorn; C Dauguet; B Mignotte; M L Gougeon
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

8.  Identification of antiparasitic drug targets using a multi-omics workflow in the acanthocephalan model.

Authors:  Hanno Schmidt; Katharina Mauer; Manuel Glaser; Bahram Sayyaf Dezfuli; Sören Lukas Hellmann; Ana Lúcia Silva Gomes; Falk Butter; Rebecca C Wade; Thomas Hankeln; Holger Herlyn
Journal:  BMC Genomics       Date:  2022-09-30       Impact factor: 4.547

9.  Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro.

Authors:  L I Huschtscha; W A Bartier; C E Ross; M H Tattersall
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.